InvestorsHub Logo
Followers 33
Posts 3736
Boards Moderated 0
Alias Born 10/31/2008

Re: None

Friday, 09/21/2018 5:09:38 PM

Friday, September 21, 2018 5:09:38 PM

Post# of 403047
Menon no long playing an active role in daily IPIX functions is an interesting development.

Celgene just walked away from a licensing deal with OncoMed for their Navicixizumab drug.

Navicixizumab is currently in a Phase Ib trial in combination with paclitaxel in patients with platinum-resistant late-stage ovarian cancer.

Last night I started wondering if Celgene was interested in Kevetrin. Today I'm even more curious.

“Be sincere, Be brief, Be seated.” - Franklin Delano Roosevelt

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News